Principal Investigator
Hadar Lev-Tov
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250415
Clinical Trial Summary
Selective Treatment of Oral Povorcitinib Long-Term Rollover Study (STOP-LTR). A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other